The availability of HEPA-filtered rooms and the incidence of pneumonia in patients after haematopoietic stem cell transplantation (HSCT): results from a prospective, multicentre, eastern European study

被引:23
作者
Vokurka, Samuel [1 ]
Bystricka, Eva [1 ]
Svoboda, Tomas [1 ]
Gorican, Irena Katja Skoda [2 ]
Sever, Matjaz [2 ]
Mazur, Ewa [3 ]
Kopinska, Anna [3 ]
Pavlicova, Vladislava [4 ]
Mocanu, Otilia [5 ]
Tanase, Alina [5 ]
Ghelase, Rodica [5 ]
Zitkova, Marie [6 ,7 ]
Labudikova, Monika [8 ]
Raida, Ludek [8 ]
Hrabankova-Navratilova, Darja [9 ]
Bockova, Jana [10 ]
机构
[1] Univ Hosp Plzen, Plzen, Pilsen, Czech Republic
[2] Univ Med Ctr Ljubljana, Dept Hematol, Ljubljana, Slovenia
[3] Med Acad Katowice, Dept Haematol & BMT, Katowice, Poland
[4] Univ Hosp Hradec Kralove, Hematol Clin, Hradec Kralove, Czech Republic
[5] Fundeni Clin Inst Bucharest, BMT Unit, Bucharest, Romania
[6] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[7] Masaryk Univ, Brno, Czech Republic
[8] Univ Hosp Olomouc, Olomouc, Czech Republic
[9] Univ Hosp Prague, Internal Clin Hematol 1, Prague, Czech Republic
[10] Pasteur Univ Hosp Kosice, Kosice, Slovakia
关键词
isolation; transplantation; stem cell; nursing; barrier nursing; pneumonia; HEPA; protection; PREVENTION; INFECTION;
D O I
10.1111/jocn.12286
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Aims and objectives To establish the availability of High Efficiency Particulate Air (HEPA)- and nonHEPA-filtered rooms in eastern European transplant centres and to investigate the impact on incidence of pneumonia and mortality after haematopoietic stem cell transplantation (HSCT). Background Barrier nursing in HEPA-filtered rooms is generally recommended for patients undergoing HSCT. There are only limited data on the availability of HEPA-filtered rooms and the impact on incidence of pneumonia and mortality. Design A prospective, observational, international study. Methods Monitoring cards were distributed within the East Forum EBMT-Nurses Group cooperating centres, and 689 consecutive patients were registered in 1/2010-6/2012. Patients were monitored for 100days post-transplant. Results In patients undergoing autologous HSCT, pneumonia developed in 14/400 (3 center dot 5%) and was the cause of death in 2/14 (14%) of patients. There was no significant difference in mortality between HEPA-filtered and nonHEPA-filtered groups (4 center dot 5% vs. 4 center dot 9%, respectively). 239/400 (59%) transplantations were performed in single-bed rooms [190/239 (79%) HEPA-filtered] and 161 (41%) in two-bed rooms [28/161 (17%) HEPA-filtered]. In allogeneic transplantation, pneumonia developed in 24/289 (8 center dot 3%) and was the cause of death in 11/24 (45%) of patients. There was no significant difference in mortality between HEPA-filtered and non-HEPA-filtered groups (14% vs. 17%, respectively). 281/289 (97%) of allogeneic transplantations were performed in single-bed rooms [254/281 (90%) HEPA-filtered], and pneumonia was more frequent in patients on corticosteroids and in rooms without HEPA. Conclusion The incidence of pneumonia in the autologous transplantation setting is low. More pneumonia was observed in the allogeneic HSCT group, especially in patients on corticosteroids. There was a trend towards a lower incidence of pneumonia in allogeneic HSCT patients treated in HEPA-filtered rooms. Relevance to clinical practice Autologous HSCT transplantation may safely be performed without HEPA filtration. HEPA filtration might be preferable in patients undergoing allogeneic transplantation.
引用
收藏
页码:1648 / 1652
页数:5
相关论文
共 8 条
[1]  
Brun CP, 2012, EPIDEMIOLOGY INFECT, V13, P1
[2]   The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients:: A systematic review [J].
Eckmanns, T ;
Rüden, H ;
Gastmeier, P .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (10) :1408-1418
[3]   Guidelines and surveys:: Hematopoietic angiogenesis -: Practices of infectious disease prevention and management during hematopoietic stem cell transplantation:: A survey from the European Group for Blood and Marrow Transplantation [J].
Krüger, WH ;
Hornung, RJ ;
Hertenstein, B ;
Kern, WV ;
Kröger, N ;
Ljungman, P ;
Zander, AR .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (06) :895-903
[4]   Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India [J].
Kumar, R. ;
Naithani, R. ;
Mishra, P. ;
Mahapatra, M. ;
Seth, T. ;
Dolai, T. K. ;
Bhargava, R. ;
Saxena, R. .
BONE MARROW TRANSPLANTATION, 2009, 43 (02) :115-119
[5]   Variation in Supportive Care Practices in Hematopoietic Cell Transplantation [J].
Lee, Stephanie J. ;
Astigarraga, Claudia C. ;
Eapen, Mary ;
Artz, Andrew S. ;
Davies, Stella M. ;
Champlin, Richard ;
Jagasia, Madan ;
Kernan, Nancy A. ;
Loberiza, Fausto R., Jr. ;
Bevans, Margaret ;
Soiffer, Robert J. ;
Joffe, Steven .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (11) :1231-1238
[6]  
Mank Arno, 2003, Eur J Oncol Nurs, V7, P17, DOI 10.1054/ejon.2002.0216
[7]   Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation [J].
Svahn, BM ;
Ringdén, O ;
Remberger, M .
BONE MARROW TRANSPLANTATION, 2005, 36 (06) :511-516
[8]   Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated [J].
Yokoe, D. ;
Casper, C. ;
Dubberke, E. ;
Lee, G. ;
Munoz, P. ;
Palmore, T. ;
Sepkowitz, K. ;
Young, J-A H. ;
Donnelly, J. P. .
BONE MARROW TRANSPLANTATION, 2009, 44 (08) :495-507